I wonder if it would be worth PAR looking into the role iPPS could have on COVID-19 patients?
The drug is known to have anti-viral properties. It also acts as an anti-inflammatory, and one of the main mysteries of COVID-19 is the multiple blood clots it can cause throughout the body. This rapid clotting usually leads to death. Given iPPS is a mild blood thinner, this is another big tick.
Yes, I know trials take a long, long time, but it seems every drug on earth is currently being looked at as a possible cure all.
https://www.nature.com/articles/d41586-020-01403-8
*Link above, in case it is blocked by hot copper, is nature dot com / articles / d41586-020-01403-8
COVID-19 and the role of iPPS
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.030(10.9%) |
Mkt cap ! $85.7M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 27.5¢ | 24.0¢ | $429.9K | 1.713M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 161991 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 29634 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.0¢ |
Change
-0.030 ( 7.51 %) |
||||
| Open | High | Low | Volume | ||
| 27.0¢ | 27.0¢ | 23.5¢ | 433775 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| PAR (ASX) Chart |